Where does Charité—universitätsmedizin Berlin rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Charité—universitätsmedizin Berlin ranks #7,249 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Charité—universitätsmedizin Berlin hold?

Charité—universitätsmedizin Berlin holds 45 US utility patents granted between 2015 and 2025, spanning 29 technology areas.

What is Charité—universitätsmedizin Berlin's Innovation Score?

Charité—universitätsmedizin Berlin has an Innovation Score of 44.8 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Charité—universitätsmedizin Berlin's patent grant rate increasing or decreasing?

Charité—universitätsmedizin Berlin's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Charité—universitätsmedizin Berlin's patents?

Charité—universitätsmedizin Berlin's patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Charité—universitätsmedizin Berlin patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Charité—universitätsmedizin Berlin

Q: What technology areas does Charité—universitätsmedizin Berlin focus on?

Charité—universitätsmedizin Berlin's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 19 patents. Grants appear in 29 CPC subclasses total.

USPTO PatentsView assignee record - 45 granted patents across 29 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Charité—universitätsmedizin ranks #7,249 of 50,000 tracked US assignees by granted-patent volume, with 45 patents across 29 technology areas.

#7,249
of 50,000 US assignees by volume: Top 25%
by Innovation Score (44.8/100): 12.1
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7249 · Foreign Corporation #7,249 · 45 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 45 grants
UPPER-Q #7,249/50,000
PHOTO-FINISH Blue Evolution
CPC-FOCUS A61K · 29 areas
INNOV-PAR 44.8/100
CLAIMS-RICH 12.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Blue Evolution Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Charité—universitäts… · this assignee

45
Fiserv · near

45
Metall + Plastic · near

45
Sterlite · near

45
Zhen Ding Technology · near

45
3D Lighting Innovati… · lowest

7

What this shows Charité—universitätsmedizin Berlin stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-FRNCORP, VEL-FLAT, BOOK-FULL. Volume places it #7,249 of 50,000; Innovation Score 44.8/100 sits in the top 25% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Blue Evolution Inc. (±0 grants).

Portfolio overview

Charité—universitätsmedizin Berlin has been granted 45 US utility patents between 2015 and 2025, placing Charité—universitätsmedizin Berlin at #7,249 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 29 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Charité—universitätsmedizin Berlin is one of the more focused assignees in the PatentsView dataset. By volume, Charité—universitätsmedizin sits between Blue Evolution Inc. (45 patents, rank #7,245) and Cool Gear International, Llc (45 patents, rank #7,253) - the closest US assignees by grant volume. The composite Innovation Score of 44.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 21 grants, compared with 21 in the 2015–2019 window, a +0% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Charité—universitätsmedizin Berlin's 12.1 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 29 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Blue Evolution

45
California Expand…

45
CDW

45
Cetres Holdings

45
Constellium Issoi…

45
Corsair Memory

45
Collision Communi…

45
Cool Gear Interna…

45
CharitÉ—Universit… ◀

45

What this shows Charité—universitätsmedizin holds 45 patents at rank #7,249, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Charité—universitätsmedizin

By rank, the assignees closest to #7,249 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Charité—universitätsmedizin's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Charité—universitätsmedizin, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Fiserv, Inc. 45 Zhen Ding Technology Co., Ltd. 45 Sterlite Technologies Limited 45 Metall + Plastic Gmbh 45

Charité—universitätsmedizin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Charité—universitätsmedizin Berlin patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	8.9%
2016	5	11.1%
2017	2	4.4%
2018	6	13.3%
2019	4	8.9%
2020	4	8.9%
2021	6	13.3%
2022	1	2.2%
2023	5	11.1%
2024	5	11.1%
2025partial year	3	6.7%

Which technologies does Charité—universitätsmedizin Berlin patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 19

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 18

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12

C07K - PEPTIDES 12

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 12

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 8

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 7

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 3

C07D - HETEROCYCLIC COMPOUNDS 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 3

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 3

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 3

B01D - SEPARATION 2

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 2

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 2

Top 15 of 29 technology areas

Where it ranks

Overall rank by patents

#7,249

of 50,000 tracked assignees

Innovation Score

44.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Cite this page

PlainPatent, “Charité—universitätsmedizin Berlin Patent Portfolio.” Compiled from the underlying federal/official data source; data as of 2015–2025. https://plainpatent.com/company/charit%C3%A9universit%C3%A4tsmedizin-berlin/

Formal citation formats (APA / MLA)

APA: PlainPatent. (2015). Charité—universitätsmedizin Berlin Patent Portfolio. Retrieved August 22, 2026, from https://plainpatent.com/company/charit%C3%A9universit%C3%A4tsmedizin-berlin/

MLA: "Charité—universitätsmedizin Berlin Patent Portfolio." PlainPatent, 2015, https://plainpatent.com/company/charit%C3%A9universit%C3%A4tsmedizin-berlin/.

You are welcome to quote these figures with attribution to PlainPatent and the underlying source. The URL above is stable. See our Terms of Use for what reuse is permitted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.